BackLegence Class A Common stock Overview

Legence Class A Common stock Total Liabilities

Legence Class A Common stock's total liabilities is $2.5B.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$2.53B
17.72% YoYΔ $381.20M vs prior year quarter

Peer average

Loading

Legence Class A Common stock Total Liabilities History

Loading

Legence Class A Common stock vs. peers: Total Liabilities Comparison

Loading

Legence Class A Common stock Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Legence Class A Common stock (LGN) FAQ

Legence Class A Common stock's total liabilities stands at $2.5B as of March 2026. That compares with $2.2B in the prior-year period — up 17.7% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Legence Class A Common stock reported $2.5B in total liabilities versus $2.2B a year earlier — a 17.7% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $2.2B in the prior-year period — up 17.7% year over year. Sustained growth in total liabilities can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Legence Class A Common stock's total liabilities evolved across reporting periods, while the comparison chart places LGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, total liabilities is commonly used to spot outliers. Legence Class A Common stock's reading of $2.5B is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.